Apr 23 |
Tarsus refinances existing debt with $200M financing commitment
|
Apr 23 |
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
|
Apr 19 |
Insider Returns Down To US$166k As Tarsus Pharmaceuticals' Stock Dips 14%
|
Apr 8 |
Wall Street Analysts Predict a 47.12% Upside in Tarsus Pharmaceuticals (TARS): Here's What You Should Know
|
Apr 4 |
Aggressive Stock Portfolio: 13 Stocks Picked by Analysts
|
Apr 1 |
Tarsus Pharmaceuticals (TARS) Upgraded to Buy: Here's Why
|
Mar 8 |
Tarsus Pharmaceuticals: A Strong Launch For An Under The Radar Name
|
Mar 6 |
How Much Upside is Left in Tarsus Pharmaceuticals, Inc. (TARS)? Wall Street Analysts Think 37.91%
|
Mar 5 |
Tarsus to Participate at Upcoming Investor Conferences
|
Mar 5 |
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
|